Dan A Erkes

5PUBLICATIONS
32CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 10, 2026
S-phase targeted treatment triggers caspase-dependent lytic immunogenic cell death with pyroptotic features in cancers.

|Nov 26, 2025
Pyroptosis Modulates Multiple Immune Cell Populations in Targeted Therapy-Treated Melanoma.

Nicole A Wilski-Cronin, Dan A Erkes, Timothy J Purwin

|Jul 31, 2025
Elevated Transglutaminase-2 in SOX10-Deficient Melanoma Promotes Tumor Onset and Decreases Intratumoral CD4+ T Cells.

Signe Caksa, Timothy J Purwin, Dan A Erkes

|Dec 13, 2024
Metabolic Inhibition Induces Pyroptosis in Uveal Melanoma.

Scott D Varney, Dan A Erkes, Glenn L Mersky

|Jun 13, 2017
Intratumoral infection by CMV may change the tumor environment by directly interacting with tumor-associated macrophages to promote cancer immunity.

Dan A Erkes, Nicole A Wilski, Christopher M Snyder

Pageof 1

Frequent Collaborators

4 joint publications

Andrew E Aplin

3 joint publications

Inna Chervoneva

3 joint publications

Timothy J Purwin

2 joint publications

Nicole A Wilski-Cronin